Apyx Medical Corp Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Apyx Medical Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Apyx Medical Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.64M, a 21.6% increase year-over-year.
  • Apyx Medical Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$21.6M, a 23.9% decline year-over-year.
  • Apyx Medical Corp annual Operating Income (Loss) for 2023 was -$17.3M, a 26.8% increase from 2022.
  • Apyx Medical Corp annual Operating Income (Loss) for 2022 was -$23.6M, a 63.1% decline from 2021.
  • Apyx Medical Corp annual Operating Income (Loss) for 2021 was -$14.4M, a 28.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$21.6M -$3.64M +$1M +21.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$22.6M -$5.55M -$4.31M -349% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$18.3M -$6.62M -$1M -17.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$17.3M -$5.78M +$157K +2.65% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$17.4M -$4.64M +$1.15M +19.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$18.6M -$1.24M +$4.74M +79.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$23.3M -$5.61M +$260K +4.43% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$23.6M -$5.93M -$4.24M -251% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$19.3M -$5.78M -$1.81M -45.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$17.5M -$5.98M -$1.93M -47.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$15.6M -$5.87M -$1.13M -23.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$14.4M -$1.69M +$361K +17.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$14.8M -$3.97M +$403K +9.22% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$15.2M -$4.04M +$2.12M +34.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$17.3M -$4.75M +$2.75M +36.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$20.1M -$2.05M +$3.91M +65.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$24M -$4.37M +$385K +8.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$24.4M -$6.17M -$1.75M -39.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$22.6M -$7.49M -$1.76M -30.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$20.9M -$5.96M -$126K -2.16% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$20.7M -$4.76M -$1.97M -70.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$18.8M -$4.42M -$1.49M -50.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$17.3M -$5.73M -$3.01M -111% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$14.3M -$5.84M +$2.17M +27.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-31
Q3 2018 -$16.5M -$2.79M +$45K +1.59% Jul 1, 2018 Sep 30, 2018 10-Q/A 2020-05-08
Q2 2018 -$16.5M -$2.93M -$1.63M -125% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$14.9M -$2.72M -$983K -56.6% Jan 1, 2018 Mar 31, 2018 10-Q/A 2020-05-08
Q4 2017 -$13.9M -$8.01M +$635K +7.35% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-31
Q3 2017 -$14.5M -$2.83M -$2.59M -1056% Jul 1, 2017 Sep 30, 2017 10-Q/A 2020-05-08
Q2 2017 -$11.9M -$1.31M -$796K -156% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$11.1M -$1.74M +$256K +12.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$11.4M -$8.64M -$7.29M -539% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 -$4.1M -$245K +$1.57M +86.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$5.67M -$510K +$1.04M +67.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$6.71M -$1.99M +$279K +12.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$6.99M -$1.35M +$441K +24.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-13
Q3 2015 -$7.43M -$1.81M +$554K +23.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 -$7.98M -$1.55M +$198K +11.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 -$8.18M -$2.27M -$2.33M -4017% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$5.85M -$1.79M -$918K -105% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$4.93M -$2.37M -$1.89M -398% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$3.04M -$1.75M -$96K -5.82% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$2.94M $58K +$723K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$3.67M -$876K -$1M -784% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-18
Q3 2013 -$2.66M -$475K -$757K -268% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$1.91M -$1.65M -$1.89M -788% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$15K -$665K -$1.06M -268% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $1.05M $128K +$1.53M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 -$482K $282K +$34K +13.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$516K $240K -$309K -56.3% Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-09-25
Q1 2012 -$207K $396K -$189K -32.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$18K -$1.4M Oct 1, 2011 Dec 31, 2011 10-K/A 2014-05-08
Q3 2011 $248K +$363K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $549K +$1.34M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $585K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$115K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$791K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.